fludarabine has been researched along with Central Nervous System Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morgensztern, D; Peddi, PF; Peddi, S; Santos, ES | 1 |
Groeneveld, ON; Kersten, MJ; Kraan, W; Linn, C; Minnema, MC; Pals, ST; Vos, JM | 1 |
Cho, HS; Hyun, MS; Kim, HD; Kim, MK; Lee, KH; Shin, KC | 1 |
1 review(s) available for fludarabine and Central Nervous System Diseases
Article | Year |
---|---|
Central nervous system toxicities of chemotherapeutic agents.
Topics: Antineoplastic Agents; Central Nervous System Diseases; Cisplatin; Cytarabine; Fluorouracil; Humans; Ifosfamide; Methotrexate; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Vidarabine; Vincristine | 2014 |
2 other study(ies) available for fludarabine and Central Nervous System Diseases
Article | Year |
---|---|
Effective treatment of Bing-Neel Syndrome with oral fludarabine: a case series of four consecutive patients.
Topics: Administration, Oral; Adult; Aged; Central Nervous System Diseases; Female; Humans; Male; Middle Aged; Treatment Outcome; Vidarabine; Waldenstrom Macroglobulinemia | 2016 |
Therapeutic experience of Bing-Neel Syndrome associated with Waldenstrom's macroglobulinemia.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Brain; Central Nervous System Diseases; Cranial Irradiation; Female; Humans; Middle Aged; Rituximab; Syndrome; Vidarabine; Waldenstrom Macroglobulinemia | 2007 |